SEC CIK 1244389

Baker Biotech Capital (GP), LLC

Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
INCYview stock →2,933,0212010-09-23
BCRXview stock →1,541,6002009-06-01

Position History — BCRX

Reported shares owned immediately after each Form 4 transaction, over time.

0586,1641,172,3291,758,4932007-082008-112008-112008-112009-052009-052009-052009-052009-062009-06

Recent Filings — BCRX

DateActivitySharesPriceOwned After
2009-06-01Open-market sale50,574$3.861,541,600
2009-06-01Open-market sale19,585$3.891,522,015
2009-05-29Open-market sale48,438$4.121,592,174
2009-05-29Open-market sale9,409$4.301,640,612
2009-05-28Open-market sale69,762$4.501,650,021
2009-05-28Open-market sale38,710$4.451,719,783
2008-11-24Open-market buy2,339$0.981,758,493
2008-11-21Open-market buy9,831$0.911,756,154
2008-11-20Open-market buy96,033$1.001,746,323
2007-08-06———1,650,290

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.